Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. (BOLT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BOLT · as of Jun 9, 2026
Activity summary
Buy transactions
4
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Bolt Biotherapeutics, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
BOLT insider buying and selling by quarter
BOLT insider selling · BOLT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · BOLT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
BOLT executive sell shares · BOLT board member insider trading · BOLT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Dec 5, 2025 | Quinn William P. President, CEO and CFO · Director | Purchase | 125 | $576 | Form 4 |
| Dec 5, 2025 | Nemec Sarah Senior VP, Finance and PAO | Purchase | 125 | $576 | Form 4 |
Quinn William P.
President, CEO and CFO · Director
Date
Dec 5
Shares
125
Price
$4.61
Value
$576
Nemec Sarah
Senior VP, Finance and PAO
Date
Dec 5
Shares
125
Price
$4.61
Value
$576
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BOLT insider trading
BOLT insider trades
Bolt Biotherapeutics, Inc. (BOLT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Quinn William P. (President, CEO and CFO · Director), Nemec Sarah (Senior VP, Finance and PAO). Over the past 12 months, 2 insiders have filed transactions with the SEC. BOLT insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Bolt Biotherapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BOLT insider trading · 5 questionsThe insiders of Bolt Biotherapeutics, Inc. (BOLT) include executives and directors such as Quinn William P. (President, CEO and CFO · Director), Nemec Sarah (Senior VP, Finance and PAO), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026